Connect Biopharma Holdings Stock Price History
CNTB Stock | USD 1.11 0.03 2.78% |
If you're considering investing in Connect Stock, it is important to understand the factors that can impact its price. As of today, the current price of Connect Biopharma stands at 1.11, as last reported on the 4th of December, with the highest price reaching 1.12 and the lowest price hitting 0.98 during the day. At this point, Connect Biopharma is very risky. Connect Biopharma secures Sharpe Ratio (or Efficiency) of 0.0014, which signifies that the company had a 0.0014% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Connect Biopharma Holdings, which you can use to evaluate the volatility of the firm. Please confirm Connect Biopharma's Risk Adjusted Performance of (0.05), standard deviation of 5.43, and Mean Deviation of 3.93 to double-check if the risk estimate we provide is consistent with the expected return of 0.0069%.
At present, Connect Biopharma's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 10.1 K, whereas Common Stock Shares Outstanding is forecasted to decline to about 43.5 M. . At present, Connect Biopharma's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price Earnings Ratio is forecasted to decline to (1.15). Connect Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Connect |
Sharpe Ratio = 0.0014
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CNTB |
Estimated Market Risk
4.9 actual daily | 43 57% of assets are more volatile |
Expected Return
0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Connect Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Connect Biopharma by adding Connect Biopharma to a well-diversified portfolio.
Price Book 0.5376 | Enterprise Value Ebitda 0.1857 | Price Sales 2.5317 | Shares Float 14.8 M | Wall Street Target Price 7 |
Connect Biopharma Stock Price History Chart
There are several ways to analyze Connect Stock price data. The simplest method is using a basic Connect candlestick price chart, which shows Connect Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 3, 2024 | 1.47 |
Lowest Price | November 26, 2024 | 0.97 |
Connect Biopharma December 4, 2024 Stock Price Synopsis
Various analyses of Connect Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Connect Stock. It can be used to describe the percentage change in the price of Connect Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Connect Stock.Connect Biopharma Price Rate Of Daily Change | 1.03 | |
Connect Biopharma Price Daily Balance Of Power | 0.21 | |
Connect Biopharma Price Action Indicator | 0.08 |
Connect Biopharma December 4, 2024 Stock Price Analysis
Connect Stock Price History Data
The price series of Connect Biopharma for the period between Thu, Sep 5, 2024 and Wed, Dec 4, 2024 has a statistical range of 0.63 with a coefficient of variation of 11.07. The prices are distributed with arithmetic mean of 1.21. The median price for the last 90 days is 1.22.Open | High | Low | Close | Volume | ||
12/04/2024 | 1.07 | 1.12 | 0.98 | 1.11 | ||
12/03/2024 | 1.07 | 1.12 | 0.98 | 1.11 | 37,117 | |
12/02/2024 | 1.02 | 1.09 | 1.02 | 1.08 | 30,006 | |
11/29/2024 | 0.99 | 1.08 | 0.99 | 1.06 | 13,523 | |
11/27/2024 | 0.98 | 1.05 | 0.94 | 1.03 | 39,163 | |
11/26/2024 | 0.97 | 1.01 | 0.92 | 0.97 | 49,836 | |
11/25/2024 | 0.96 | 0.99 | 0.96 | 0.98 | 22,082 | |
11/22/2024 | 1.04 | 1.04 | 0.99 | 1.00 | 7,818 | |
11/21/2024 | 0.95 | 1.05 | 0.95 | 0.99 | 14,113 | |
11/20/2024 | 0.92 | 1.05 | 0.91 | 1.05 | 12,744 | |
11/19/2024 | 1.02 | 1.02 | 0.95 | 0.98 | 27,413 | |
11/18/2024 | 1.11 | 1.11 | 0.98 | 1.01 | 21,259 | |
11/15/2024 | 1.05 | 1.11 | 0.98 | 1.11 | 34,063 | |
11/14/2024 | 1.01 | 1.01 | 0.98 | 0.99 | 17,550 | |
11/13/2024 | 1.03 | 1.09 | 1.00 | 1.00 | 22,848 | |
11/12/2024 | 1.08 | 1.08 | 1.01 | 1.04 | 15,920 | |
11/11/2024 | 1.16 | 1.16 | 0.99 | 1.05 | 31,451 | |
11/08/2024 | 1.08 | 1.18 | 1.08 | 1.12 | 3,220 | |
11/07/2024 | 1.13 | 1.17 | 1.11 | 1.13 | 3,136 | |
11/06/2024 | 1.20 | 1.22 | 1.01 | 1.19 | 168,510 | |
11/05/2024 | 1.25 | 1.28 | 1.20 | 1.24 | 16,071 | |
11/04/2024 | 1.22 | 1.40 | 1.18 | 1.20 | 99,432 | |
11/01/2024 | 1.22 | 1.24 | 1.15 | 1.18 | 26,875 | |
10/31/2024 | 1.17 | 1.18 | 1.16 | 1.16 | 8,842 | |
10/30/2024 | 1.18 | 1.18 | 1.16 | 1.17 | 15,626 | |
10/29/2024 | 1.23 | 1.23 | 1.18 | 1.20 | 8,039 | |
10/28/2024 | 1.20 | 1.26 | 1.20 | 1.26 | 20,151 | |
10/25/2024 | 1.16 | 1.21 | 1.16 | 1.19 | 26,500 | |
10/24/2024 | 1.22 | 1.22 | 1.21 | 1.22 | 5,731 | |
10/23/2024 | 1.22 | 1.22 | 1.16 | 1.22 | 2,734 | |
10/22/2024 | 1.21 | 1.22 | 1.18 | 1.22 | 15,995 | |
10/21/2024 | 1.20 | 1.23 | 1.14 | 1.21 | 33,281 | |
10/18/2024 | 1.25 | 1.25 | 1.25 | 1.25 | 1,521 | |
10/17/2024 | 1.23 | 1.30 | 1.22 | 1.24 | 9,442 | |
10/16/2024 | 1.35 | 1.35 | 1.22 | 1.25 | 9,258 | |
10/15/2024 | 1.38 | 1.38 | 1.26 | 1.26 | 17,389 | |
10/14/2024 | 1.22 | 1.44 | 1.22 | 1.40 | 13,576 | |
10/11/2024 | 1.33 | 1.36 | 1.24 | 1.24 | 36,575 | |
10/10/2024 | 1.27 | 1.38 | 1.26 | 1.26 | 10,139 | |
10/09/2024 | 1.28 | 1.36 | 1.21 | 1.35 | 36,117 | |
10/08/2024 | 1.26 | 1.31 | 1.22 | 1.28 | 33,572 | |
10/07/2024 | 1.31 | 1.47 | 1.24 | 1.26 | 113,918 | |
10/04/2024 | 1.52 | 1.52 | 1.39 | 1.41 | 38,613 | |
10/03/2024 | 1.45 | 1.48 | 1.38 | 1.47 | 36,100 | |
10/02/2024 | 1.44 | 1.51 | 1.43 | 1.45 | 24,463 | |
10/01/2024 | 1.39 | 1.44 | 1.38 | 1.41 | 4,258 | |
09/30/2024 | 1.35 | 1.51 | 1.35 | 1.44 | 49,546 | |
09/27/2024 | 1.40 | 1.45 | 1.35 | 1.35 | 10,455 | |
09/26/2024 | 1.38 | 1.50 | 1.29 | 1.41 | 61,975 | |
09/25/2024 | 1.23 | 1.30 | 1.23 | 1.28 | 14,089 | |
09/24/2024 | 1.22 | 1.23 | 1.21 | 1.23 | 8,770 | |
09/23/2024 | 1.20 | 1.23 | 1.20 | 1.22 | 5,064 | |
09/20/2024 | 1.23 | 1.23 | 1.22 | 1.23 | 1,544 | |
09/19/2024 | 1.25 | 1.25 | 1.20 | 1.24 | 5,428 | |
09/18/2024 | 1.29 | 1.30 | 1.16 | 1.18 | 23,438 | |
09/17/2024 | 1.20 | 1.33 | 1.18 | 1.28 | 11,103 | |
09/16/2024 | 1.18 | 1.27 | 1.12 | 1.18 | 15,535 | |
09/13/2024 | 1.25 | 1.25 | 1.20 | 1.23 | 8,772 | |
09/12/2024 | 1.15 | 1.26 | 1.15 | 1.20 | 7,076 | |
09/11/2024 | 1.23 | 1.27 | 1.23 | 1.26 | 5,172 | |
09/10/2024 | 1.25 | 1.30 | 1.13 | 1.27 | 24,026 |
About Connect Biopharma Stock history
Connect Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Connect is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Connect Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Connect Biopharma stock prices may prove useful in developing a viable investing in Connect Biopharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 55.1 M | 43.5 M | |
Net Loss | -1.2 B | -1.1 B |
Connect Biopharma Quarterly Net Working Capital |
|
Connect Biopharma Stock Technical Analysis
Connect Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
All Next | Launch Module |
Connect Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Connect Biopharma's price direction in advance. Along with the technical and fundamental analysis of Connect Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Connect to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.54) | |||
Total Risk Alpha | (1.15) | |||
Treynor Ratio | (0.33) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Connect Stock analysis
When running Connect Biopharma's price analysis, check to measure Connect Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Connect Biopharma is operating at the current time. Most of Connect Biopharma's value examination focuses on studying past and present price action to predict the probability of Connect Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Connect Biopharma's price. Additionally, you may evaluate how the addition of Connect Biopharma to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |